Gene · 1460
Papers1,702
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,702
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Peptide design to control protein-protein interactions. | Chem Soc Rev | 2025 | 39817557 | PubTator, text mining | PubMed |
| CSNK2B Mutation: A Rare Cause of IGHD. | Clin Endocrinol (Oxf) | 2025 | 39676320 | PubTator, text mining | PubMed |
| Circadian Control of Protein Synthesis. | Bioessays | 2025 | 39668398 | PubTator, text mining | PubMed |
| Single-Cell Omics for Transcriptome CHaracterization (SCOTCH): isoform-level characterization of gene expression through long-read single-cell RNA sequencing. | bioRxiv | 2025 | 38746128 | PubTator, text mining | PubMed |
| Structure-Activity Relationship Studies of Tetracyclic Pyrrolocarbazoles Inhibiting Heterotetrameric Protein Kinase CK2. | Molecules | 2024 | 39795120 | PubTator, text mining | PubMed |
| Curzerenone inactivates the nuclear factor-kappa B signaling to suppress malignancy and immune evasion in cervical cancer by targeting CSNK2B. | Hum Cell | 2024 | 39718697 | PubTator, text mining | PubMed |
| Lung development genes, adult lung function and cognitive traits. | Brain Commun | 2024 | 39544701 | PubTator, text mining | PubMed |
| Case report: Novel deletions in the 6p21.33 involving the CSNK2B gene in patients with Poirier-Bienvenu neurodevelopmental syndrome and literature review. | Front Med (Lausanne) | 2024 | 39493709 | PubTator, text mining | PubMed |
| Silmitasertib (CX-4945) Disrupts ERα/HSP90 Interaction and Drives Proteolysis through the Disruption of CK2β Function in Breast Cancer Cells. | Cancers (Basel) | 2024 | 39061141 | PubTator, text mining | PubMed |
| Distinctive expression and cellular localisation of zinc homeostasis-related proteins in breast and prostate cancer cells. | J Trace Elem Med Biol | 2024 | 39047373 | PubTator, text mining | PubMed |
| Characterization of 13 Novel Genetic Variants in Genes Associated with Epilepsy: Implications for Targeted Therapeutic Strategies. | Mol Diagn Ther | 2024 | 39003674 | PubTator, text mining | PubMed |
| Mitophagy and clear cell renal cell carcinoma: insights from single-cell and spatial transcriptomics analysis. | Front Immunol | 2024 | 38994370 | PubTator, text mining | PubMed |
| Exploration of mitochondrial autophagy related genes in the diagnosis model construction and molecular marker mining of Alzheimer's disease based on multi-omics integration. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38836671 | PubTator, text mining | PubMed |
| Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy. | Front Immunol | 2024 | 38807597 | PubTator, text mining | PubMed |
| Phylogenomic profiles of whole-genome duplications in Poaceae and landscape of differential duplicate retention and losses among major Poaceae lineages. | Nat Commun | 2024 | 38632270 | PubTator, text mining | PubMed |
| Effect of high-hydrostatic pressure on the digestibility of egg yolk and granule. | J Food Sci | 2024 | 38551196 | PubTator, text mining | PubMed |
| Meta-analysis of 46,000 germline de novo mutations linked to human inherited disease. | Hum Genomics | 2024 | 38395944 | PubTator, text mining | PubMed |
| Huaier suppresses cell viability, migration and invasion in human non-small cell lung cancer via lncRNA DLEU2/miR-212-5p/ELF3 axis. | Int J Med Sci | 2024 | 38169645 | PubTator, text mining | PubMed |
| Genetic analysis and literature review of a Poirier-Bienvenu neurodevelopmental syndrome family line caused by a de novo frameshift variant in CSNK2B. | Mol Genet Genomic Med | 2024 | 38037515 | PubTator, text mining | PubMed |
| CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular Carcinoma. | Recent Pat Anticancer Drug Discov | 2024 | 37779404 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1460/papers?page=3